|
| 36858678 | Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma. | Lancet Haematol | 2023 |
| 36352192 | Frequency and prognostic implications of KMT2A rearrangements in children with precursor B-cell lymphoma. | Leukemia | 2023 |
| 36332176 | EBV-driven lymphoid neoplasms associated with pediatric ALL maintenance therapy. | Blood | 2023 |
| 37638834 | F-FDG-PET/CT imaging in diagnostic workup of pediatric precursor B-cell lymphoblastic lymphoma. | | 2023 |
| 36907639 | Diagnosis and management of lymphoblastic lymphoma in children, adolescents and young adults. | | 2023 |
| 37275738 | Hypersensitivity Reactions to Native L-asparaginase in Children With Acute Lymphoblastic Leukemia Treated in Trial ALL-BFM 2000: Impact of Treatment Schedule and Type of Glucocorticoid in Induction. | | 2023 |
| 36572834 | Letermovir for Prophylaxis and Pre-emptive Therapy of Cytomegalovirus Infection in Paediatric Allogeneic Haematopoietic Cell Transplant Patients. | | 2023 |
| 36748962 | Parvovirus B19 infection in pediatric allogeneic hematopoietic cell transplantation - Single-center experience and review. | Transpl Infect Dis | 2023 |
| 36541957 | Ibrutinib plus RICE or RVICI for relapsed/refractory mature B-cell non-Hodgkin lymphoma in children and young adults: SPARKLE trial. | | 2023 |
| 34939314 | Patient parameters and response after administration of rituximab in pediatric mature B-cell non-Hodgkin lymphoma. | Pediatric Blood and Cancer | 2022 |
| 36097283 | Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL - long-term follow-up from the prospective ALL-SCT 2003 trial. | Leukemia | 2022 |
| 36010889 | Pediatric Precursor B-Cell Lymphoblastic Malignancies: From Extramedullary to Medullary Involvement. | Cancers | 2022 |
| 35620592 | The EHA Research Roadmap: Malignant Lymphoid Diseases. | HemaSphere | 2022 |
| 35794096 | Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age. | Nat Commun | 2022 |
| 35790817 | Characterization of IG-MYC-breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric Burkitt-lymphoma and -leukemia. | Leukemia | 2022 |
| 36522349 | Burkitt lymphoma. | | 2022 |
| 35278000 | Design of a targeted next-generation DNA sequencing panel for pediatric T-cell lymphoblastic lymphoma to unravel biology and optimize treatment. | Genes Chromosomes Cancer | 2022 |
| 34617271 | Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features. | Br J Haematol | 2022 |
| 34373263 | The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets. | Cancer Discov | 2021 |
| 32299903 | Second malignancies after treatment of childhood non-Hodgkin lymphoma: a report of the Berlin-Frankfurt-Muenster study group. | Haematologica | 2021 |
| 32404974 | Reconstructing clonal evolution in relapsed and non-relapsed Burkitt lymphoma. | Leukemia | 2021 |
| 32393843 | Second malignant neoplasms after treatment of non-Hodgkin's lymphoma-a retrospective multinational study of 189 children and adolescents. | Leukemia | 2021 |
| 33764500 | Primary post-transplant lymphoproliferative disorder of the central nervous system: characteristics, management and outcome in 25 paediatric patients. | British Journal of Haematology | 2021 |
| 33923026 | Treatment and Outcome Analysis of 639 Relapsed Non-Hodgkin Lymphomas in Children and Adolescents and Resulting Treatment Recommendations. | Cancers | 2021 |
| 33152759 | Integrative genomic analysis of pediatric T-cell lymphoblastic lymphoma reveals candidates of clinical significance. | Blood | 2021 |
| 33332189 | Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study. | Journal of Clinical Oncology | 2021 |
| 34785792 | Publisher Correction: Reconstructing clonal evolution in relapsed and non-relapsed Burkitt lymphoma. | Leukemia | 2021 |
| 34390161 | Molecular features of non-anaplastic peripheral T-cell lymphoma in children and adolescents. | Pediatric Blood and Cancer | 2021 |
| 34498443 | Dose-adjusted EPOCH-rituximab or intensified B-NHL therapy for pediatric primary mediastinal large B-cell lymphoma. | Haematologica | 2021 |
| 31073073 | Cryptic insertion of <i>MYC</i> exons 2 and 3 into the immunoglobulin heavy chain locus detected by whole genome sequencing in a case of "<i>MYC</i>-negative" Burkitt lymphoma. | Haematologica | 2020 |
| 32267023 | Outcome of patients with Fanconi anemia developing myelodysplasia and acute leukemia who received allogeneic hematopoietic stem cell transplantation: A retrospective analysis on behalf of EBMT group. | Am J Hematol | 2020 |
| 32203268 | Treosulfan-fludarabine-thiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignancies. | Bone Marrow Transplantation | 2020 |
| 31961927 | Progressive or relapsed Burkitt lymphoma or leukemia in children and adolescents after BFM-type first-line therapy. | Blood | 2020 |
| 32071430 | Ibrutinib plus CIT for R/R mature B-NHL in children (SPARKLE trial): initial safety, pharmacokinetics, and efficacy. | Leukemia | 2020 |
| 32239695 | Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group. | British Journal of Haematology | 2020 |
| 31578451 | Hematopoietic stem cell transplantation for children with acute myeloid leukemia-results of the AML SCT-BFM 2007 trial. | Leukemia | 2020 |
| 32343795 | Favorable outcomes of hematopoietic stem cell transplantation in children and adolescents with Diamond-Blackfan anemia. | Blood advances | 2020 |
| 31768014 | Correction: Hematopoietic stem cell transplantation for children with acute myeloid leukemia-results of the AML SCT-BFM 2007 trial. | Leukemia | 2020 |
| 31661569 | Epidemiology, utilisation of healthcare resources and outcome of invasive fungal diseases following paediatric allogeneic haematopoietic stem cell transplantation. | Mycoses | 2020 |
| 31611629 | Treatment and outcome of IG-MYC neoplasms with precursor B-cell phenotype in childhood and adolescence. | Leukemia | 2020 |
| 32452165 | Rare non-Hodgkin lymphoma of childhood and adolescence: A consensus diagnostic and therapeutic approach to pediatric-type follicular lymphoma, marginal zone lymphoma, and nonanaplastic peripheral T-cell lymphoma. | Pediatr Blood Cancer | 2020 |
| 32987765 | Prognostic Factors in Childhood Anaplastic Large Cell Lymphoma: Long Term Results of the International ALCL99 Trial. | Cancers (Basel) | 2020 |
| 33135740 | CopyDetective: Detection threshold-aware copy number variant calling in whole-exome sequencing data. | GigaScience | 2020 |
| 32618429 | Risk factors for mixed chimerism in children with hemophagocytic lymphohistiocytosis after reduced toxicity conditioning. | Pediatr Blood Cancer | 2020 |
| 30772656 | ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children. | Eur J Cancer | 2019 |
| 31869415 | Primary central nervous system lymphoma: initial features, outcome, and late effects in 75 children and adolescents. | Blood advances | 2019 |
| 30408331 | CD38 is not expressed in pediatric ALK-positive anaplastic large cell lymphoma. | Pediatric Blood and Cancer | 2019 |
| 30076176 | Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma. | Haematologica | 2019 |
| 30586230 | Solid organ transplantation after hematopoietic stem cell transplantation in childhood: A multicentric retrospective survey. | American Journal of Transplantation | 2019 |
| 30578714 | Non-leukemic pediatric mixed phenotype acute leukemia/lymphoma: Genomic characterization and clinical outcome in a prospective trial for pediatric lymphoblastic lymphoma. | Genes Chromosomes and Cancer | 2019 |